GlaxoSmithKline has replaced the head of its China operations with one of its top two European managers, as the UK-based drugs company seeks to battle a widening corruption investigation.
The company on Thursday appointed Hervé Gisserot as its new head of operations in China. He will take over from Mark Reilly, who left Shanghai in early July and will continue to assist in handling the company’s own investigation into the scandal from London. Mr Gisserot was previously co-head of GSK’s pharmaceutical business in Europe.
The decision marks the first stage of a shake-up at the top of the group in the wake of corruption allegations which GSK has dubbed “shameful”.
您已阅读21%（667字），剩余79%（2484字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。